Grace Therapeutics
GRCE
12 hedge funds and large institutions have $6.3M invested in Grace Therapeutics in 2024 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 1 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
200% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 1
45% more capital invested
Capital invested by funds: $4.34M → $6.3M (+$1.96M)
20% more funds holding
Funds holding: 10 → 12 (+2)
9.44% more ownership
Funds ownership: 13.46% → 22.9% (+9.4%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$2.24M |
| 2 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$433K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$17.5K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$3.45K |
| 5 |
AWM
Activest Wealth Management
Aventure,
Florida
|
+$314 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$18.1K |
| 2 |
NS
NBC Securities
Birmingham,
Alabama
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
ACM
1
ADAR1 Capital Management
Austin,
Texas
| $2.8M | +$2.24M | +742,190 | +341% |
|
|
ACM
2
AIGH Capital Management
Baltimore,
Maryland
| $1.88M | +$433K | +143,724 | +29% |
|
3
Bank of America
Charlotte,
North Carolina
| $1.44M | – | – | – |
|
|
4
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $113K | +$3.45K | +1,143 | +3% |
|
|
5
UBS Group
Zurich,
Switzerland
| $22.6K | +$17.5K | +5,788 | +297% |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $20K | -$18.1K | -6,000 | -48% |
|
7
National Bank of Canada
Montreal,
Quebec, Canada
| $8.29K | – | – | – |
|
8
Morgan Stanley
New York
| $5.5K | – | – | – |
|
|
AWM
9
Activest Wealth Management
Aventure,
Florida
| $304 | +$314 | +104 | New |
|
|
FDCDDQ
10
Federation des caisses Desjardins du Quebec
Levis,
Quebec, Canada
| $82 | – | – | – |
|
|
IA
11
IFP Advisors
Tampa,
Florida
| $18 | +$18 | +6 | New |
|
12
JP Morgan Chase
New York
| $6 | +$6 | +2 | New |
|
|
NS
13
NBC Securities
Birmingham,
Alabama
| – | -$1K | -2 | Closed |
|
GRCE Hedge Fund Activity: Q2 2024 in Review
12 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Grace Therapeutics (GRCE) for Q2 2024, worth a combined $6.3M — up 45% from $4.34M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new GRCE positions and 1 closed out — a net gain of 2 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was ADAR1 Capital Management, adding an estimated $2.24M. The largest seller was Royal Bank of Canada, cutting an estimated $18.1K.
- 12 institutional investors held Grace Therapeutics (GRCE) as of Q2 2024, up from 10 in Q1 2024.
- Funds reported $6.3M of Grace Therapeutics stock for Q2 2024, up 45% quarter-over-quarter.
- 3 funds opened new Grace Therapeutics positions in Q2 2024 and 1 closed out, a net change of +2 holders.
- The largest Grace Therapeutics buyer in Q2 2024 was ADAR1 Capital Management, an estimated $2.24M added.
- The largest Grace Therapeutics seller in Q2 2024 was Royal Bank of Canada, an estimated $18.1K sold.
Based on aggregated 13F filings for Q2 2024.